Ali Behbahani - Jul 1, 2024 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ Zachary Bambach, attorney-in-fact
Stock symbol
ADAP
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
4
Date filed
7/1/2024, 05:10 PM
Previous filing
Jun 21, 2024
Next filing
Sep 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +1.14M $0.00 1.14M Jul 1, 2024 Ordinary Shares 1.14M $0.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.13 based on an exchange rate of U.S.$1.263714 to GBP1.00. The actual exercise price will be the pounds sterling amount.